# Safety and Efficacy Study of GEB-101 Injection in Subjects With TGFBI-related Corneal Dystrophy

> **NCT07750678** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **GenEditBio Limited** · enrollment: 30 (estimated)

## Conditions studied

- Hereditary Corneal Dystrophy
- Corneal Abnormality
- Corneal Dystrophies
- Corneal Dystrophies, Hereditary

## Interventions

- **GENETIC:** GEB-101 Injection

## Key facts

- **NCT ID:** NCT07750678
- **Lead sponsor:** GenEditBio Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10
- **Primary completion:** 2027-08
- **Final completion:** 2028-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07750678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07750678, "Safety and Efficacy Study of GEB-101 Injection in Subjects With TGFBI-related Corneal Dystrophy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07750678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*